White Noise

White Noise

As we expected Medtronic (NYSE: MDT) is feeling the love at ATTD as the 670G continues to be the hottest topic in diabetes technology. And it should come as no surprise that try as they might these people can’t seem to grasp that there are millions of patients who do not intensively manage their diabetes. Yep big data is a big story at ATTD but we didn’t a conference to remind of us of that. There is also a ton of what we like to call white noise, meaningless study data that shows how desperate some companies are . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.